secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-01-15T23:59:59+00:00
Accession:  0001493152-26-002326
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma Board sets share limit for 2024 Stock Incentive Plan at 4,890,000 shares
--------------------------------------------------------------------------------

- Board confirmed share limit of 4,890,000 shares for the 2024 Stock Incentive Plan, which was approved by stockholders in Feb 2025.
- Approved forms of Restricted Stock Unit and Stock Option award agreements under the Plan.
- Plan allows grants of equity awards to employees, directors, and consultants to align with long-term stockholder interests.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226002326/0001493152-26-002326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226002326/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-002326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer